In the face of fierce resistance from some of Australia’s biggest banks, Apple’s attempts to gain a foothold in the country for its mobile payment service has received a significant boost from payments processor Cuscal, which says that 31 of its banking members will soon be able to access the service.
The deal with Cuscal comes as Apple awaits a ruling from the Australian Competition and Consumer Commission on an attempt by five of the country’s biggest banks to enforce collective negotiations and open up NFC access on iPhones.
The banks accuse Apple of trying to piggyback on their investment in the country’s national contactless infrastructure, while remaining “intransigent, closed and controlling” in dictating terms for support of Apple Pay.
In a fresh submission to the competition watchdog earlier this week, Apple doubled-down on its resistance, accusing the banks of acting like a ‘hard core cartel’ in stifling competition in the market.
Cuscal managing director Craig Kennedy hopes that the banks and Apple will be able to resolve their difference.
“I hope that Apple and the banks find some middle ground here because I think it would be in everybody’s interest if they found a solution for their current stalemate,” he says.
Full Content: Finextra
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas